SIRIO(SZ:300791) GOLDEN SUN SECURITIES·2026-01-11 13:00Investment Rating - The investment rating for the company is "Accumulate" [5] Core Insights - The company has signed a non-binding letter of intent for the acquisition of 100% equity in Best Formulations PC LLC (BFPC), which is expected to optimize its U.S. business structure and enhance overall profitability [1] - The company plans to issue H shares and list on the Hong Kong Stock Exchange, aiming to leverage international capital markets to accelerate its global expansion and diversify its capital operations [2] - The introduction of AI nutritionists and the JsRight precision nutrition brand is a strategic move to tap into the growing demand for personalized nutrition, aligning with consumer trends towards evidence-based health solutions [2] Financial Performance Summary - Revenue projections for 2025-2027 are estimated at 4.557 billion, 5.021 billion, and 5.539 billion CNY respectively, with growth rates of 8.2%, 10.2%, and 10.3% [4] - The net profit attributable to the parent company for the same period is forecasted to be 3.07 billion, 4.07 billion, and 5.00 billion CNY, reflecting a year-on-year change of -5.5%, +32.5%, and +22.8% [3][4] - The current price-to-earnings (P/E) ratios are projected to be 25, 19, and 15 times for the years 2025, 2026, and 2027 respectively [3][4] Revenue Breakdown - For the first half of 2025, the company's revenue from different regions is as follows: Mainland China 8.2 million, Americas 7.6 million, Europe 3.6 million, and other regions 1.0 million, accounting for 40.1%, 37.2%, 17.6%, and 5.1% of total revenue respectively [2]